Clinicians at 2022 AVA Scientific Meeting Discuss Observed CLABSI-Reductions With SecurePortIV® Adhesive

SecurePortIV In Use

At the 2022 Association for Vascular Access ("AVA") Annual Scientific Meeting, clinicians reported statistically significant reductions in dressing changes and Central Line-Associated Bloodstream Infections ("CLABSI") as a result of utilizing Adhezion Biomedical's SecurePortIV® Catheter Securement Adhesive. These findings were presented by clinicians representing seven separate institutions throughout the conference. 

Study results were presented by clinicians at Baylor Scott and White Health System (TX), Carilion Children's Hospital (VA), Froedtert Hospital (WI), Ball Memorial Hospital (IN), Houston Methodist Hospital (TX) and Cabell Huntington Hospital (WV). One such study, presented by Holly M. Rodriguez, MSN, RN, CCRN-CNC, RN-BC, and Cristina M. Nuila, MSN, RN, CNL, both from Houston Methodist Hospital, reported a 50%+ reduction in dressing changes while achieving an 88% reduction in CLABSI associated with the use of SecurePortIV® adhesive.

Pete Molinaro, Adhezion's CEO, said, "We have always known about the unique 'cidal' and protective properties of our proprietary medical cyanoacrylate formula, and it's incredibly gratifying to see the impact that SecurePortIV® catheter securement adhesive is making in PICC and PIVC Vascular Access Procedures in both infant and adult populations." The demand for SecurePortIV® adhesive continues to grow rapidly since it was recognized as a Standard of Care for vascular access securement by the Infusion Nurses Society in 2021.

About Adhezion Biomedical LLC
Adhezion Biomedical is a privately held medical device company based in Wyomissing, PA. Adhezion is committed to developing and manufacturing medical cyanoacrylate products used in the treatment of wound closure, wound management, intravenous device securement and infection prevention. To learn more about Adhezion and its products, please visit www.adhezion.com.

Source: Adhezion Biomedical, LLC

Share:


Categories: Healthcare and Medical News, Healthcare and Medical News

Tags: Adhezion Biomedical, infection prevention, SecurePortIV


About Adhezion Biomedical LLC

View Website

Adhezion Biomedical, LLC is a privately-held medical device company engaged in the development, manufacturing and commercialization of highly-differentiated, proprietary, cyanoacrylate-based adhesive and infection prevention products.

Pete Molinaro
CEO
Rachel Brizek
VP, Marketing & Administration
Adhezion Biomedical LLC
One Meridian Blvd (Suite 1B02)
Wyomissing, PA 19610
United States